Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00235118 · ClinicalTrials.gov registry record · Phase 1
Cordis Bilateral AAA Device Compared to Open Surgical Repair of Abdominal Aortic Aneurysms (ARIBA)
A Phase 1 study of Abdominal Aortic Aneurysm, sponsored by Cordis US.
- Completed
- Registry status
- Phase 1
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT00235118: Completed Phase 1 study of Abdominal Aortic Aneurysm, sponsored by Cordis US.
NCT00235118 is a Phase 1 study of Abdominal Aortic Aneurysm that has completed, run by Cordis US. The registered enrollment target is 29 participants, below the 452-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00235118, a Phase 1 study of Abdominal Aortic Aneurysm, has completed, sponsored by Cordis US.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to assess the safety and effectiveness of the Cordis Bilateral AAA device and its Delivery System compared to open surgical repair for the treatment of Abdominal Aortic Aneurysm (AAA).
Conditions Studied
Interventions
- DEVICE Cordis AAA Bilateral Device
Study Locations (1)
New York
- Mt. Sinai Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 1999-12 |
| Est. Completion | 2006-02 |
| Phase | Phase 1 |
What the finished NCT00235118 record still lists
NCT00235118 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 452-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Cordis AAA Bilateral Device is the first listed.
NCT00235118 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00235118 about?
NCT00235118 is a clinical study titled "Cordis Bilateral AAA Device Compared to Open Surgical Repair of Abdominal Aortic Aneurysms (ARIBA)". The objective of this study is to assess the safety and effectiveness of the Cordis Bilateral AAA device and its Delivery System compared to open surgical repair for the treatment of Abdominal Aortic Aneurysm (AAA).
What is the current status of trial NCT00235118?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 29 participants. The study started on 1999-12. Estimated completion is 2006-02.
What conditions does trial NCT00235118 study?
This clinical trial studies the following conditions: Abdominal Aortic Aneurysm.
What interventions are being tested in trial NCT00235118?
The interventions under investigation include: Cordis AAA Bilateral Device (DEVICE).
Who is sponsoring clinical trial NCT00235118?
This trial is sponsored by Cordis US, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00235118 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00235118's enrollment target sits among peer trials
29 14th of 16 higher than 3 of 16 other Abdominal Aortic Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Abdominal Aortic Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Terumo Aortic Global Endovascular Registry
RECRUITING
-
Limiting AAA With Metformin (LIMIT) Trial
RECRUITING · Phase 2
-
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
RECRUITING · NA
-
Nectero EAST System Clinical Study
RECRUITING · Phase 2
-
PET Imaging of MMP Activation in AAA: Clinical Component
RECRUITING · Early Phase 1
-
The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia